Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Alnylam
Sort By
Newest First
Sign in
1 / 1
1 / 1
Clinical Outcomes
Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLUMO® (lumasiran)
Alnylam Pharmaceuticals
PR-M05-21-003
May 05, 2021
COVID-19
Vir and Alnylam Identify RNAi Therapeutic Development Candidate Targeting SARS-CoV-2
Vir Biotechnology
PR-M05-20-NI-008
May 04, 2020
Partnership
Regeneron Expands Partnership with RNAi Drug Developer Alnylam
Emilie Branch
Pharma's Almanac
PAO-M04-19-NI-013
Apr 10, 2019
Genetic Testing
Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria
Invitae
PR-M11-18-NI-010
Nov 02, 2018
Distribution Agreement
Orsini Healthcare Specialty Pharmacy Selected by Alnylam Pharmaceuticals to Distribute ONPATTRO™ (patisiran)
Orsini Healthcare
PR-M09-18-NI-019
Sep 07, 2018
